Cargando…

Immunological features of patients affected by Barraquer-Simons syndrome

BACKGROUND: C3 hypocomplementemia and the presence of C3 nephritic factor (C3NeF), an autoantibody causing complement system over-activation, are common features among most patients affected by Barraquer-Simons syndrome (BSS), an acquired form of partial lipodystrophy. Moreover, BSS is frequently as...

Descripción completa

Detalles Bibliográficos
Autores principales: Corvillo, Fernando, Ceccarini, Giovanni, Nozal, Pilar, Magno, Silvia, Pelosini, Caterina, Garrido, Sofía, López-Lera, Alberto, Moraru, Manuela, Vilches, Carlos, Fornaciari, Silvia, Gabbriellini, Sabrina, Santini, Ferruccio, Araújo-Vilar, David, López-Trascasa, Margarita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954565/
https://www.ncbi.nlm.nih.gov/pubmed/31924231
http://dx.doi.org/10.1186/s13023-019-1292-1
_version_ 1783486820926881792
author Corvillo, Fernando
Ceccarini, Giovanni
Nozal, Pilar
Magno, Silvia
Pelosini, Caterina
Garrido, Sofía
López-Lera, Alberto
Moraru, Manuela
Vilches, Carlos
Fornaciari, Silvia
Gabbriellini, Sabrina
Santini, Ferruccio
Araújo-Vilar, David
López-Trascasa, Margarita
author_facet Corvillo, Fernando
Ceccarini, Giovanni
Nozal, Pilar
Magno, Silvia
Pelosini, Caterina
Garrido, Sofía
López-Lera, Alberto
Moraru, Manuela
Vilches, Carlos
Fornaciari, Silvia
Gabbriellini, Sabrina
Santini, Ferruccio
Araújo-Vilar, David
López-Trascasa, Margarita
author_sort Corvillo, Fernando
collection PubMed
description BACKGROUND: C3 hypocomplementemia and the presence of C3 nephritic factor (C3NeF), an autoantibody causing complement system over-activation, are common features among most patients affected by Barraquer-Simons syndrome (BSS), an acquired form of partial lipodystrophy. Moreover, BSS is frequently associated with autoimmune diseases. However, the relationship between complement system dysregulation and BSS remains to be fully elucidated. The aim of this study was to provide a comprehensive immunological analysis of the complement system status, autoantibody signatures and HLA profile in BSS. Thirteen subjects with BSS were recruited for the study. The circulating levels of complement components, C3, C4, Factor B (FB) and Properdin (P), as well as an extended autoantibody profile including autoantibodies targeting complement components and regulators were assessed in serum. Additionally, HLA genotyping was carried out using DNA extracted from peripheral blood mononuclear cells. RESULTS: C3, C4 and FB levels were significantly reduced in patients with BSS as compared with healthy subjects. C3NeF was the most frequently found autoantibody (69.2% of cases), followed by anti-C3 (38.5%), and anti-P and anti-FB (30.8% each). Clinical data showed high prevalence of autoimmune diseases (38.5%), the majority of patients (61.5%) being positive for at least one of the autoantibodies tested. The HLA allele DRB1*11 was present in 54% of BSS patients, and the majority of them (31%) were positive for *11:03 (vs 1.3% allelic frequency in the general population). CONCLUSIONS: Our results confirmed the association between BSS, autoimmunity and C3 hypocomplementemia. Moreover, the finding of autoantibodies targeting complement system proteins points to complement dysregulation as a central pathological event in the development of BSS.
format Online
Article
Text
id pubmed-6954565
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69545652020-01-14 Immunological features of patients affected by Barraquer-Simons syndrome Corvillo, Fernando Ceccarini, Giovanni Nozal, Pilar Magno, Silvia Pelosini, Caterina Garrido, Sofía López-Lera, Alberto Moraru, Manuela Vilches, Carlos Fornaciari, Silvia Gabbriellini, Sabrina Santini, Ferruccio Araújo-Vilar, David López-Trascasa, Margarita Orphanet J Rare Dis Research BACKGROUND: C3 hypocomplementemia and the presence of C3 nephritic factor (C3NeF), an autoantibody causing complement system over-activation, are common features among most patients affected by Barraquer-Simons syndrome (BSS), an acquired form of partial lipodystrophy. Moreover, BSS is frequently associated with autoimmune diseases. However, the relationship between complement system dysregulation and BSS remains to be fully elucidated. The aim of this study was to provide a comprehensive immunological analysis of the complement system status, autoantibody signatures and HLA profile in BSS. Thirteen subjects with BSS were recruited for the study. The circulating levels of complement components, C3, C4, Factor B (FB) and Properdin (P), as well as an extended autoantibody profile including autoantibodies targeting complement components and regulators were assessed in serum. Additionally, HLA genotyping was carried out using DNA extracted from peripheral blood mononuclear cells. RESULTS: C3, C4 and FB levels were significantly reduced in patients with BSS as compared with healthy subjects. C3NeF was the most frequently found autoantibody (69.2% of cases), followed by anti-C3 (38.5%), and anti-P and anti-FB (30.8% each). Clinical data showed high prevalence of autoimmune diseases (38.5%), the majority of patients (61.5%) being positive for at least one of the autoantibodies tested. The HLA allele DRB1*11 was present in 54% of BSS patients, and the majority of them (31%) were positive for *11:03 (vs 1.3% allelic frequency in the general population). CONCLUSIONS: Our results confirmed the association between BSS, autoimmunity and C3 hypocomplementemia. Moreover, the finding of autoantibodies targeting complement system proteins points to complement dysregulation as a central pathological event in the development of BSS. BioMed Central 2020-01-10 /pmc/articles/PMC6954565/ /pubmed/31924231 http://dx.doi.org/10.1186/s13023-019-1292-1 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Corvillo, Fernando
Ceccarini, Giovanni
Nozal, Pilar
Magno, Silvia
Pelosini, Caterina
Garrido, Sofía
López-Lera, Alberto
Moraru, Manuela
Vilches, Carlos
Fornaciari, Silvia
Gabbriellini, Sabrina
Santini, Ferruccio
Araújo-Vilar, David
López-Trascasa, Margarita
Immunological features of patients affected by Barraquer-Simons syndrome
title Immunological features of patients affected by Barraquer-Simons syndrome
title_full Immunological features of patients affected by Barraquer-Simons syndrome
title_fullStr Immunological features of patients affected by Barraquer-Simons syndrome
title_full_unstemmed Immunological features of patients affected by Barraquer-Simons syndrome
title_short Immunological features of patients affected by Barraquer-Simons syndrome
title_sort immunological features of patients affected by barraquer-simons syndrome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954565/
https://www.ncbi.nlm.nih.gov/pubmed/31924231
http://dx.doi.org/10.1186/s13023-019-1292-1
work_keys_str_mv AT corvillofernando immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome
AT ceccarinigiovanni immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome
AT nozalpilar immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome
AT magnosilvia immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome
AT pelosinicaterina immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome
AT garridosofia immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome
AT lopezleraalberto immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome
AT morarumanuela immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome
AT vilchescarlos immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome
AT fornaciarisilvia immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome
AT gabbriellinisabrina immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome
AT santiniferruccio immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome
AT araujovilardavid immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome
AT lopeztrascasamargarita immunologicalfeaturesofpatientsaffectedbybarraquersimonssyndrome